Prioritizing Small Sets of Molecules for Synthesis through in‐silico Tools: A Comparison of Common Ranking Methods
ChemMedChem · 03.01.2023 · 18 (1)
DOI: 10.1002/cmdc.202200425 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 29.11.2022. Verfasst von Marko Breznik und 8 weiteren Autor:innen. Beteiligte Einrichtung: Computational Molecular Design Pharmaceuticals, R&D, Bayer AG, 13342, Berlin, Germany. Hauptthemen laut MEDLINE: Proteins, Algorithms. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Prioritizing molecules for synthesis is a key role of computational methods within medicinal chemistry. Multiple tools exist for ranking molecules, from the cheap and popular molecular docking methods to more computationally expensive molecular‐dynamics (MD)‐based methods. It is often questioned whether the accuracy of the more rigorous methods justifies the higher computational cost and associated calculation time. Here, we compared the performance on ranking the binding of small molecules for seven scoring functions from five docking programs, one end‐point method (MM/GBSA), and two MD‐based free energy methods (PMX, FEP+). We investigated 16 pharmaceutically relevant targets with a total of 423 known binders. The performance of docking methods for ligand ranking was strongly system dependent. We observed that MD‐based methods predominantly outperformed docking algorithms and MM/GBSA calculations. Based on our results, we recommend the application of MD‐based free energy methods for prioritization of molecules for synthesis in lead optimization, whenever feasible.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Computational Molecular Design Pharmaceuticals, R&D, Bayer AG, 13342, Berlin, Germany.
- Department of Pharmaceutical Sciences, University of California, Irvine, CA 92697, USA.
- Computational Chemistry, Janssen Research & Development, Beerse, 2340, Belgium.
- Molecular Design Pharmaceuticals, R&D, Bayer AG, 13342, Berlin, Germany.
- Department of Chemistry, University of California, Irvine, CA 92697, USA.
- Computational Life Science Technology Functions Crop Science, R&D, Bayer AG, 40789, Monheim, Germany.
ORCID-Profile: Marko Breznik, Yunhui Ge, Joseph P Bluck, Hans Briem, Jérémie Mortier, Katharina Meier
Förderung
- NIGMS NIH HHS
- National Institutes of Health
Zitieren
APA
Breznik, M., Ge, Y., Bluck, J. P., Briem, H., Hahn, D. F., Christ, C. D., Mortier, J., Mobley, D. L., & Meier, K. (2023). Prioritizing Small Sets of Molecules for Synthesis through in‐silico Tools: A Comparison of Common Ranking Methods. ChemMedChem, 18(1). https://doi.org/10.1002/cmdc.202200425
Vancouver
Breznik M, Ge Y, Bluck JP, Briem H, Hahn DF, Christ CD, et al. Prioritizing Small Sets of Molecules for Synthesis through in‐silico Tools: A Comparison of Common Ranking Methods. ChemMedChem. 2023;18(1). doi:10.1002/cmdc.202200425
BibTeX
@article{Breznik2023,
author = {Breznik, Marko and Ge, Yunhui and Bluck, Joseph P and Briem, Hans and Hahn, David F and Christ, Clara D and Mortier, Jérémie and Mobley, David L and Meier, Katharina},
title = {Prioritizing Small Sets of Molecules for Synthesis through in‐silico Tools: A Comparison of Common Ranking Methods},
journal = {ChemMedChem},
year = {2023},
volume = {18},
number = {1},
doi = {10.1002/cmdc.202200425}
}
EUVIMED